-- Days : -- HRS : -- MIN : -- SEC

Register for Free →

News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Publication|Articles|October 6, 2025

Supplements and Featured Publications

The Role of TEVIMBRA® (tislelizumab-jsgr) in First-Line ESCC Treatment

The Role of TEVIMBRA® (tislelizumab-jsgr) in First-Line ESCC Treatment

This Clinical Brief was sponsored by BeOne Medicines.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.